FrontPage is India's Stock Market Social Network
Join 3,00,000+ Traders and Investors
forum
AJANTPHARM Share Price Discussion
Ajanta Pharma Ltd.
NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Sector: Pharmaceuticals and health care
newsbot's Post 
Reputation: 27,124 • May 10 1:41 AM
Ajanta Pharma Q4 Results: Net profit falls 5% to Rs 151 cr
For the year ended March 31, 2022, the company posted a PAT of Rs 713 crore. It was Rs 654 crore in FY21. Revenue from operations rose to Rs 3,341 crore last fiscal as against Rs 2,890 crore in 2020-21.
For the year ended March 31, 2022, the company posted a PAT of Rs 713 crore. It was Rs 654 crore in FY21. Revenue from operations rose to Rs 3,341 crore last fiscal as against Rs 2,890 crore in 2020-21.
The Economic Times
NSE:AJANTPHARM price when posted: 1,658.1